Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
572
mi
from
Houston, TX
GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
572
mi
from
Houston, TX
Click here to add this to my saved trials
GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated:  12/31/1969
Novartis
576
mi
from
San Antonio, TX
GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated: 12/31/1969
Novartis
576
mi
from
San Antonio, TX
Click here to add this to my saved trials
GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
779
mi
from
Salt Lake City, UT
GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
1408
mi
from
Tacoma, WA
GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
1408
mi
from
Tacoma, WA
Click here to add this to my saved trials
GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
1045
mi
from
Toronto,
GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
1045
mi
from
Toronto,
Click here to add this to my saved trials
GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
1344
mi
from
New Haven, CT
GSK1120212 Rollover Study
MEK114375: A Rollover Study to Provide Continued Treatment With GSK1120212 to Subjects With Solid Tumors or Leukemia
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Scottsdale
835
mi
from
Scottsdale, AZ
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Scottsdale
835
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Aurora Presbyterian Hospital
401
mi
from
Aurora, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Aurora Presbyterian Hospital
401
mi
from
Aurora, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Boulder Community Hospital
427
mi
from
Boulder, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Boulder Community Hospital
427
mi
from
Boulder, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Penrose Cancer Center at Penrose Hospital
398
mi
from
Colorado Springs, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Penrose Cancer Center at Penrose Hospital
398
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Presbyterian - St. Luke's Medical Center
409
mi
from
Denver, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Presbyterian - St. Luke's Medical Center
409
mi
from
Denver, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Porter Adventist Hospital
407
mi
from
Denver, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Porter Adventist Hospital
407
mi
from
Denver, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
St. Anthony Central Hospital
411
mi
from
Denver, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
St. Anthony Central Hospital
411
mi
from
Denver, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Rose Medical Center
406
mi
from
Denver, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Rose Medical Center
406
mi
from
Denver, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center
408
mi
from
Englewood, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
408
mi
from
Englewood, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Front Range Cancer Specialists
429
mi
from
Fort Collins, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Front Range Cancer Specialists
429
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Poudre Valley Hospital
434
mi
from
Fort Collins, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Poudre Valley Hospital
434
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
North Colorado Medical Center
411
mi
from
Greeley, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
North Colorado Medical Center
411
mi
from
Greeley, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Littleton Adventist Hospital
408
mi
from
Littleton, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Littleton Adventist Hospital
408
mi
from
Littleton, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Sky Ridge Medical Center
401
mi
from
Lone Tree, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Sky Ridge Medical Center
401
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Hope Cancer Care Center at Longmont United Hospital
425
mi
from
Longmont, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Hope Cancer Care Center at Longmont United Hospital
425
mi
from
Longmont, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
McKee Medical Center
433
mi
from
Loveland, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
McKee Medical Center
433
mi
from
Loveland, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Parker Adventist Hospital
393
mi
from
Parker, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Parker Adventist Hospital
393
mi
from
Parker, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
North Suburban Medical Center
410
mi
from
Thornton, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
North Suburban Medical Center
410
mi
from
Thornton, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Exempla Lutheran Medical Center
416
mi
from
Wheat Ridge, CO
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Exempla Lutheran Medical Center
416
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
1358
mi
from
Hartford, CT
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
1358
mi
from
Hartford, CT
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Herbert D. Kerman Regional Oncology Center - Daytona Beach
1130
mi
from
Daytona Beach, FL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Herbert D. Kerman Regional Oncology Center - Daytona Beach
1130
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
University of Florida Shands Cancer Center
1049
mi
from
Gainesville, FL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
University of Florida Shands Cancer Center
1049
mi
from
Gainesville, FL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
OnCare Hawaii, Incorporated - Lusitana
3717
mi
from
Honolulu, HI
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
OnCare Hawaii, Incorporated - Lusitana
3717
mi
from
Honolulu, HI
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Cancer Research Center of Hawaii
3717
mi
from
Honolulu, HI
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Cancer Research Center of Hawaii
3717
mi
from
Honolulu, HI
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Hawaii Medical Center - East
3717
mi
from
Honolulu, HI
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Hawaii Medical Center - East
3717
mi
from
Honolulu, HI
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Kapiolani Medical Center for Women and Children
1307
mi
from
Honolulu, HI
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Kapiolani Medical Center for Women and Children
1307
mi
from
Honolulu, HI
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Queen's Cancer Institute at Queen's Medical Center
3717
mi
from
Honolulu, HI
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Queen's Cancer Institute at Queen's Medical Center
3717
mi
from
Honolulu, HI
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Castle Medical Center
3677
mi
from
Kailua, HI
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Castle Medical Center
3677
mi
from
Kailua, HI
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Maui Memorial Medical Center
3659
mi
from
Wailuku, HI
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Maui Memorial Medical Center
3659
mi
from
Wailuku, HI
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Pacific Cancer Institute - Maui
3659
mi
from
Wailuku, HI
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Pacific Cancer Institute - Maui
3659
mi
from
Wailuku, HI
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
1041
mi
from
Boise, ID
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
1041
mi
from
Boise, ID
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Idaho Urologic Institute, P.A.
1050
mi
from
Meridian, ID
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Idaho Urologic Institute, P.A.
1050
mi
from
Meridian, ID
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
St. Joseph Medical Center
508
mi
from
Bloomington, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
St. Joseph Medical Center
508
mi
from
Bloomington, IL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare-Bloomington
511
mi
from
Bloomington, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare-Bloomington
511
mi
from
Bloomington, IL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Canton
460
mi
from
Canton, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Canton
460
mi
from
Canton, IL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Carthage
403
mi
from
Carthage, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Carthage
403
mi
from
Carthage, IL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Eureka
501
mi
from
Eureka, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Eureka
501
mi
from
Eureka, IL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Eureka Community Hospital
501
mi
from
Eureka, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Eureka Community Hospital
501
mi
from
Eureka, IL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Galesburg Clinic, PC
455
mi
from
Galesburg, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Galesburg Clinic, PC
455
mi
from
Galesburg, IL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Havana
452
mi
from
Havana, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Havana
452
mi
from
Havana, IL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Kewanee Clinic
484
mi
from
Kewanee, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Kewanee Clinic
484
mi
from
Kewanee, IL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Macomb
426
mi
from
Macomb, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Macomb
426
mi
from
Macomb, IL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
467
mi
from
Moline, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
467
mi
from
Moline, IL
Click here to add this to my saved trials
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Monmouth
441
mi
from
Monmouth, IL
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Monmouth
441
mi
from
Monmouth, IL
Click here to add this to my saved trials